» Articles » PMID: 28503348

Emerging Trends in the Epidemiological Pattern of Head and Neck Cancers in Lagos, Nigeria

Overview
Specialty General Medicine
Date 2017 May 16
PMID 28503348
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Unfortunately, despite an increase in medical knowledge, survival rates of head and neck cancers (HNCs) have not been observed to improve greatly. This is true, especially in tumors located in obscure primary sites or late presentation.

Aim: The purpose of this study is to assess the epidemiologic pattern of HNCs and to evaluate its emerging trends and patterns in Lagos state.

Subjects And Methods: A retrospective study was conducted from 2003 to 2013 that analyzed histologically diagnosed cases of HNC at the Pathology Departments of the two tertiary teaching hospitals in Lagos. Data analysis was performed using the Statistical Package for the Social Sciences (version 20) statistical software.

Results: One thousand and eighty-three cases of head and neck malignancies were recorded. A female: male ratio of 1.01:1 was reported with mean age of 39.6 (standard deviation 21.1) years. The oral cavity was the most affected anatomic site (21.2%, 230/1083) in the period under review. Malignant epithelial tumors accounted for 72% (779/1083) of cases seen. Carcinomas were the most common histological variant seen (67%, 726/1083) and squamous cell carcinoma accounted for 58% (421/726) of carcinomas recorded. Oral cavity malignancies (21.8%, 118/540) were the most common in males while thyroid malignancies (28.5%, 155/543) were the most seen in females. In children (≤15 years), the most common histologic findings were carcinomas (42.3%; 77/182) and retinoblastomas (23.6%; 43/182).

Conclusion: Epithelial malignancies were the most common malignancy in the study, and the oral cavity appears to be the increasingly predominant site for HNCs. A changing pattern in gender predominance, age distribution, and frequency with histological variants and anatomical sites was also observed in this study.

Citing Articles

Epidemiology and demographics of head and neck cancer in Africa: A scoping review.

Seedat J, Coutts K, Vlok E Afr J Prim Health Care Fam Med. 2023; 15(1):e1-e13.

PMID: 37526561 PMC: 11022662. DOI: 10.4102/phcfm.v15i1.3749.


Esophageal and Head and Neck Cancer Patients Attending Ocean Road Cancer Institute in Tanzania from 2019 to 2021: An Observational Study.

Mwelange L, Mamuya S, Mwaiselage J, Bratveit M, Moen B Int J Environ Res Public Health. 2023; 20(4).

PMID: 36833998 PMC: 9962976. DOI: 10.3390/ijerph20043305.


Knowledge of senior secondary school students in Nigeria about Head and Neck Cancer: Implications on prevention strategies.

Kanmodi K, Fagbule O, Ogbeide M, Ogunniyi K, Isola T, Samuel V Malawi Med J. 2022; 34(3):162-169.

PMID: 36406094 PMC: 9641603. DOI: 10.4314/mmj.v34i3.4.


Dysphagia and its impact on the quality of life of head and neck cancer patients: institution-based cross-sectional study.

Yifru T, Kisa S, Dinegde N, Atnafu N BMC Res Notes. 2021; 14(1):11.

PMID: 33413623 PMC: 7791825. DOI: 10.1186/s13104-020-05440-4.


Overexpression of lincRNA02471 promote cancer development though miR-758/HIPK3 signaling pathway in papillary thyroid cancer.

Ji L, Chen W, Fan X, Zhou F, Deng X, Gu J Am J Transl Res. 2020; 12(2):531-540.

PMID: 32194901 PMC: 7061828.


References
1.
Adeyemi B, Adekunle L, Kolude B, Akang E, Lawoyin J . Head and neck cancer--a clinicopathological study in a tertiary care center. J Natl Med Assoc. 2008; 100(6):690-7. DOI: 10.1016/s0027-9684(15)31343-2. View

2.
Morhason-Bello I, Odedina F, Rebbeck T, Harford J, Dangou J, Denny L . Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol. 2013; 14(4):e142-51. DOI: 10.1016/S1470-2045(12)70482-5. View

3.
Bhattacharjee A, Chakraborty A, Purkaystha P . Prevalence of head and neck cancers in the north east-An institutional study. Indian J Otolaryngol Head Neck Surg. 2012; 58(1):15-9. PMC: 3450618. DOI: 10.1007/BF02907731. View

4.
Kingham T, Alatise O, Vanderpuye V, Casper C, Abantanga F, Kamara T . Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 2013; 14(4):e158-67. DOI: 10.1016/S1470-2045(12)70472-2. View

5.
Adisa A, Adeyemi B, Oluwasola A, Kolude B, Akang E, Lawoyin J . Clinico-pathological profile of head and neck malignancies at University College Hospital, Ibadan, Nigeria. Head Face Med. 2011; 7:9. PMC: 3115889. DOI: 10.1186/1746-160X-7-9. View